What happens next in GLP-1 — and when.

Get the briefing

What moved in the GLP‑1 field, in your inbox.

@glp1briefing

My Journey

Notes on following this field closely — what the data looks like from the inside, what surprised me, and what I got wrong.

This section is personal, and the rest of the site is not. Every other page here is a rendering of primary records — registry entries, regulatory filings, published papers — with no interpretation added. These posts are my own account and nothing more. They are not medical advice, they contain no dosing guidance, and nothing here should inform a treatment decision. That is a conversation for you and your clinician.

No posts yet.

The first one is being written. In the meantime, the changes feed is where the actual news shows up.